S,

M A Cobleigh1, F E Norlock, D M Oleske

  • 1Section of Medical Oncology, Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill 60612, USA.

JAMA
|May 5, 1999
PubMed
まとめ

閉経後のホルモン置換療法 (HRT) の使用は,エストロゲン受容体陽性乳がんの成長を刺激するように見え,これはより高いS相分数によって示されます. ER陰性腫瘍と予後に対する影響は不明である.

関連する概念動画

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...